Abbott Financial Statements (ABT)

Abbottsmart-lab.ru %   2023Q3 2023Q4 2023Q4 2024Q1 2024Q1   LTM ?
Report date 01.11.2023 31.12.2023 16.02.2024 31.03.2024 02.05.2024   02.05.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 10 143 10 241 10 241 9 964 9 964   40 410
Operating Income, bln rub 1 769 1 840 1 864 1 450 1 450   6 604
EBITDA, bln rub ? 2 593 2 664 2 677 1 450 1 450   8 241
Net profit, bln rub ? 1 436 1 594 1 594 1 225 1 225   5 638
OCF, bln rub ? 1 877 0.000 3 038 0.000 1 025   4 063
CAPEX, bln rub ? 560.0 0.000 755.0 0.000 398.0   1 153
FCF, bln rub ? 1 317 0.000 2 283 0.000 627.0   2 910
Dividend payout, bln rub 888.0 0.000 888.0 0.000 957.0   1 845
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 61.8% 0.00% 55.7% 0.00% 78.1%   32.7%
OPEX, bln rub 3 798 3 850 3 394 4 094 4 094   15 432
Cost of production, bln rub 4 605 4 526 4 983 4 420 4 420   18 349
R&D, bln rub 672.0 700.0 690.0 679.0 679.0   2 748
Interest expenses, bln rub 166.0 0.000 235.0 61.0 61.0   357.0
Assets, bln rub 72 090 0.000 73 214 0.000 72 467   72 467
Net Assets, bln rub ? 37 481 37 694 38 603 38 827 38 810   38 810
Debt, bln rub 15 528 0.000 15 873 0.000 14 586   14 586
Cash, bln rub 7 047 7 047 7 279 7 279 6 651   6 651
Net debt, bln rub 8 481 -7 047 8 594 -7 279 7 935   7 935
Ordinary share price, rub 96.9 110.1 110.1 113.7 113.7   95.9
Number of ordinary shares, mln 1 739 1 752 1 734 1 734 1 734   1 734
Market cap, bln rub 168 393 192 804 190 870 197 095 197 095   166 298
EV, bln rub ? 176 874 185 757 199 464 189 816 205 030   174 233
Book value, bln rub 4 922 37 694 6 109 38 827 7 131   7 131
EPS, rub ? 0.83 0.91 0.92 0.71 0.71   3.25
FCF/share, rub 0.76 0.00 1.32 0.00 0.36   1.68
BV/share, rub 2.83 21.5 3.52 22.4 4.11   4.11
EBITDA margin, % ? 25.6% 26.0% 26.1% 14.6% 14.6%   20.4%
Net margin, % ? 14.2% 15.6% 15.6% 12.3% 12.3%   14.0%
FCF yield, % ? 2.67% 1.44% 2.65% 2.18% 2.50%   1.75%
ROE, % ? 13.8% 15.2% 14.8% 14.5% 14.5%   14.5%
ROA, % ? 7.16% 7.82% 7.77%   7.78%
P/E ? 32.6 33.7 33.4 35.0 35.0   29.5
P/FCF 37.5 37.7 45.9 40.0   57.1
P/S ? 4.21 4.81 4.76 4.89 4.89   4.12
P/BV ? 34.2 5.11 31.2 5.08 27.6   23.3
EV/EBITDA ? 18.8 18.2 19.5 20.7 22.3   21.1
Debt/EBITDA 0.90 -0.69 0.84 -0.79 0.86   0.96
R&D/CAPEX, % 120.0% 91.4% 170.6%   238.3%
CAPEX/Revenue, % 5.52% 0.00% 7.37% 0.00% 3.99%   2.85%
Abbott shareholders